FDA Approves Bixlenvo, a Single Tablet Option for Adults With HIV

Reports

4

Domains carrying it

4

First reported

28 August 2026

Latest report

31 August 2026

◆ Sectors

◆ Where

United States

◆ Timeline

1. 28 August 2026FDA Approves Bixlenvo, a Single Tablet Option for Adults With HIVdrugtopics.com
2. 31 August 2026FDA Approves Bixlenvo for HIV-1 Switch Therapy in Virologically Suppressed Adultspatientcareonline.com

◆ Connected developments

Situations Wire finds semantically close to this one. Proximity, not cause.

• FDA Expands Dolutegravir Approval to Infants With HIV-1 Weighing at Least 2 kg4 reports · 4 domains · 3 September 2026
• FDA Approves Ropeginterferon Alfa-2b for Essential Thrombocythemia11 reports · 10 domains · 2 September 2026
• U.S. FDA Grants Accelerated Approval to Bristol Myers Squibb's First CELMoD Therapy ...12 reports · 12 domains · 17 August 2026
• US FDA approves Replimune's skin cancer drug15 reports · 14 domains · 10 August 2026
• FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder14 reports · 12 domains · 1 September 2026
• FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer59 reports · 51 domains · 5 September 2026

◆ Share

◆ Evidence

4 reports · 4 domains

• FDA Approves Bixlenvo for HIV-1 Switch Therapy in Virologically Suppressed Adultspatientcareonline.com · 31 August 2026
• FDA approval BIC LEN HIV Drug Bixlenvo Gileadidse.net · 28 August 2026
• Bictegravir-Lenacapavir Combo Pill Earns FDA Approval in Suppressed HIVmedpagetoday.com · 28 August 2026
• FDA Approves Bixlenvo, a Single Tablet Option for Adults With HIVdrugtopics.com · 28 August 2026